The Patent Finder

Galderma Research & Development, S.N.C.

Also on record
Records under this name other than the patents Galderma Research & Development, S.N.C. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Galderma Research & Development, S.N.C.

PatentTitleStatus Expires Confidence
US 8,784,905Oil-Extracted Product of Indigo Naturalis, and Preparation Process and Uses Thereof
Formerly held
Lapsed on the fee record
Ended Jul 22, 2026 · High confidence
Lapsed on the fee recordEnded Jul 22, 2026High confidence
US 7,439,396Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
Term ended
Term ended May 23, 2026 · From the USPTO record
Term endedTerm ended May 23, 2026From the USPTO record
US 7,820,186Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Term ended
Term ended Nov 23, 2025 · From the USPTO record
Term endedTerm ended Nov 23, 2025From the USPTO record
US 7,579,377Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Term ended
Term ended Feb 23, 2025 · From the USPTO record
Term endedTerm ended Feb 23, 2025From the USPTO record
US 7,348,449Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
Term ended
Term ended Nov 17, 2024 · From the USPTO record
Term endedTerm ended Nov 17, 2024From the USPTO record
US 7,468,457Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
Term ended
Term ended Sep 5, 2024 · From the USPTO record
Term endedTerm ended Sep 5, 2024From the USPTO record
US 7,964,202Method for treatment of common acne
Term ended
Term ended Sep 1, 2024 · From the USPTO record
Term endedTerm ended Sep 1, 2024From the USPTO record
US 7,326,803Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
Term ended
Term ended Mar 25, 2024 · From the USPTO record
Term endedTerm ended Mar 25, 2024From the USPTO record
US 7,838,558Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Lapsed on the fee record
Ended Nov 23, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 23, 2022From the USPTO record
US 6,403,656Use of ppar-&ggr; activators in dermatology
Term ended
Term ended Sep 7, 2020 · From the USPTO record
Term endedTerm ended Sep 7, 2020From the USPTO record
10 of 47 patents shown.
Pro members see all 47.
Pro members: see all 47 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited